Arcellx ($ACLX) Insider Trading & Smart Money Activity

Arcellx Inc · Biotechnology · Latest filing May 15, 2026

Arcellx Inc ($ACLX) has 8 13F position changes on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
8
Analyst ratings on file
0

ACLX insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 8 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ACLX insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Verition Fund Management New +187.35K sh $21.56M Read
13F Tudor Investment Added +416.56K sh $53.23M —
13F Tudor Investment Added +416.56K sh $53.23M —
13F Pentwater Capital Management New +2.87M sh $330.25M —
13F Lmr Partners New +212.50K sh $24.45M —
13F Lmr Partners New +212.50K sh $24.45M —
13F Balyasny Asset Management L.P. New +479.76K sh $55.21M —
13F Balyasny Asset Management L.P. New +479.76K sh $55.21M —

1W / 1M / 6M = how ACLX moved from the trade or filing date.

Institutions moving ACLX (13F)

Frequently asked questions

Which institutions changed their ACLX positions?

Recent 13F filers moving the stock include Tudor Investment, Lmr Partners, Balyasny Asset Management L.P., Verition Fund Management and Pentwater Capital Management.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text